N. Zamberlan

1.2k total citations
23 papers, 998 citations indexed

About

N. Zamberlan is a scholar working on Orthopedics and Sports Medicine, Oncology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, N. Zamberlan has authored 23 papers receiving a total of 998 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Orthopedics and Sports Medicine, 10 papers in Oncology and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in N. Zamberlan's work include Bone health and osteoporosis research (15 papers), Bone health and treatments (10 papers) and Bone and Joint Diseases (6 papers). N. Zamberlan is often cited by papers focused on Bone health and osteoporosis research (15 papers), Bone health and treatments (10 papers) and Bone and Joint Diseases (6 papers). N. Zamberlan collaborates with scholars based in Italy, United States and Belgium. N. Zamberlan's co-authors include Silvano Adami, Maurizio Rossini, Davide Gatti, S. Adámi, V. Braga, Francesco Bertoldo, Romolo M. Dorizzi, Vincenzo Lo Cascio, Roberto Castello and Flavia Tosi and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Journal of Bone and Mineral Research and Bone.

In The Last Decade

N. Zamberlan

23 papers receiving 949 citations

Peers

N. Zamberlan
Comparison fields: 5 of 95
  • Orthopedics and Sports Medicine 574
  • Oncology 539
  • Molecular Biology 208
  • Endocrinology, Diabetes and Metabolism 172
  • Genetics 151
Larry M. Kohse United States
Y. Boutsen Belgium
S. E. Papapoulos Netherlands
Silvano Adami Italy
Walter A. Merz Switzerland
G. F. Mazzuoli Italy
M. Jesús Martínez de Osaba Spain
D Kuntz France
J. Dequeker Belgium
Fergus E. McKiernan United States
Larry M. Kohse United States View profile →
Citations per field, relative to N. Zamberlan
N. Zamberlan · 1×
Citations per year, relative to N. Zamberlan
N. Zamberlan · 1×

Countries citing papers authored by N. Zamberlan

Since Specialization
Citations

This map shows the geographic impact of N. Zamberlan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Zamberlan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Zamberlan more than expected).

Fields of papers citing papers by N. Zamberlan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. Zamberlan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Zamberlan. The network helps show where N. Zamberlan may publish in the future.

Co-authorship network of co-authors of N. Zamberlan

This figure shows the co-authorship network connecting the top 25 collaborators of N. Zamberlan. A scholar is included among the top collaborators of N. Zamberlan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. Zamberlan. N. Zamberlan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Title Journal Authors Indexed citations
1 Spironolactone, But Not Flutamide, Administration Prevents Bone Loss in Hyperandrogenic Women Treated with Gonadotropin-Releasing Hormone Agonist1 The Journal of Clinical Endocrinology & Metabolism Paolo Moghetti, Roberto Castello et al. 26
2 Intramuscular clodronate therapy in postmenopausal osteoporosis Bone Maurizio Rossini, V. Braga et al. 36
3 Effect of hyperandrogenism and menstrual cycle abnormalities on bone mass and bone turnover in young women Clinical Endocrinology S. Adami, N. Zamberlan et al. 69
4 Bone Measurements in Asymptomatic Primary Hyperparathyroidism Bone S. Adámi, V. Braga et al. 35
5 Effect of Hyperandrogenism and Menstrual Cycle Abnormalities on Bone Mass and Bone Turnover in Young Women Obstetrical & Gynecological Survey S. Adami, N. Zamberlan et al. 4
6 Intermittent etidronate partially prevents bone loss in hirsute hyperandrogenic women treated with GnRH agonist Osteoporosis International N. Zamberlan, Roberto Castello et al. 8
7 Computed radiographic absorptiometry and morphometry in the assessment of postmenopausal bone loss Osteoporosis International S. Adámi, N. Zamberlan et al. 46
8 Effect of aging on trabecular and compact bone components of proximal and ultradistal radius Osteoporosis International Davide Gatti, Maurizio Rossini et al. 52
9 Evaluation of cortical thickness and bone density by roentgen microdensitometry in growing males and females European Journal of Pediatrics N. Zamberlan, Giorgio Radetti et al. 47
10 Exercise increases cortical/trabecular bone mass ratio Osteoporosis International S. Adámi, Maurizio Rossini et al. 1
11 Adverse Effects of Bisphosphonates Drug Safety Silvano Adami, N. Zamberlan 306
12 Evaluation of cortical thickness and bone density by roentgen microdensitometry in growing males and females European Journal of Pediatrics N. Zamberlan, Giorgio Radetti et al. 2
13 Clinical Utility of a Wheat-Germ Precipitation Assay for Determination of Bone Alkaline Phosphatase Concentrations in Patients with Different Metabolic Bone Diseases Clinical Chemistry and Laboratory Medicine (CCLM) V. Braga, Romolo M. Dorizzi et al. 8
14 Duration of the effects of intravenous alendronate in postmenopausal women and in patients with primary hyperparathyroidism and Paget's disease of bone Bone and Mineral S. Adámi, N. Zamberlan et al. 48
15 Effects of two oral doses of alendronate in the treatment of Paget's disease of bone Bone S. Adámi, M. Mian et al. 54
16 Therapeutic strategies in osteoporosis : whom to treat and when treatment of postmenopausal bone loss : long-term strategies Bone and Mineral S. Adami, V. Braga et al. 1
17 Long-term effects of transdermal and oral estrogens on serum lipids and lipoproteins in postmenopausal women Maturitas Silvano Adami, Maurizio Rossini et al. 48
18 The effects of menopause and estrogen replacement therapy on the renal handling of calcium Osteoporosis International S. Adámi, Davide Gatti et al. 48
19 91288901 The prevention of corticosteroid-induced osteoporosis with nandrolone decanoate Maturitas S. Adámi, V. Fossaluzza et al. 6
20 The prevention of corticosteroid-induced osteoporosis with nandrolone decanoate Bone and Mineral S. Adámi, V. Fossaluzza et al. 45

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026